作为一名皮肤科医生和dermatopathologist，肯尼斯仔，医学博士，博士，一直对预防鳞状细胞癌的他的目光 - 皮肤癌的第二个最常见的形式在美国。
Annual Report 2013 : seminal discoveries, seismic changes
The resistance fighter
Historically, research and patient care have been kept separate or “siloed.” Guillermo Garcia-Manero wants to change that.
图文：悦McSpadden
An expert in blood cancers and translational medicine, Garcia-Manero, M.D., professor in白血病，注意到，骨髓增生异常综合征（MDS），其中，所述骨髓不能产生足够的血细胞，通常建立到前线药物抗性如去甲基化药物。
反过来，这些患者发生急性髓系白血病（AML），当没有足够成熟的血细胞，防止贫血，感染或出血恰好。去甲基化剂，其靶DNA，消除快速分裂的细胞而不伤害正常的。
Through MD Anderson’sAML/MDS Moon Shot，加西亚 - Manero被揭示为耐药性的发展对这些药剂的分子基础。换句话说，他试图发现什么变化的时候，患者的身体抵抗药物发生，它停止工作。
Understanding these changes is critical, according to Garcia-Manero, because resistance to hypomethylating agents also correlates with resistance to other drugs and, ultimately, poor patient prognosis
Unlike the genome, the presence and activity of proteins vary in each cell to support its unique functions. Garcia-Manero anticipates that identifying changes in protein type, levels and modifications in cells — a process called proteomic analysis — will reveal biomarkers that predict sensitivity, response and/or resistance to drugs. It also may uncover targets for new therapies.
MD安德森白血病中心
- 在世界上最大的白血病程序
- 国际知名医师
- 更多than 150 active clinical trials
- Access to investigational agents
48,610 people diagnosed with leukemia in the U.S. in 2013
- 15,680 cases of chronic lymphocytic leukemia
- 14,590 cases of acute myeloid leukemia
- 6,070 cases of acute lymphocytic leukemia
- 5920例慢性骨髓leukemia
更多故事从年报
Working for inheritors of higher risk
人与提高他们患某些癌症，如结肠癌，处理大量的忧虑来自于对自己的健康不确定性的风险遗传条件。我们希望，爱德华维拉尔 - 桑切斯的工作，总有一天会缓解这种风险。
Paving the way for trailblazers
达拉斯小牛队的利达·希尔决心帮助解决‘谜是癌症。’
卵巢癌筛查的考验，成绩令人鼓舞
An old blood test now offers new hope and possibility.
MD Anderson's 'protein pioneer'
1983年,罗伯特·韧皮Jr .),医学博士,and his colleagues published a seminal paper in the New England Journal of Medicine detailing his discovery of the protein CA-125 and its value in helping to predict if ovarian cancer might recur.
对癌症革命战争
Imagine if oncologists around the world had access to the expertise of MD Anderson’s physicians. The standard of cancer care would be greatly improved, and lives would be saved.
Triumph after a trial and tribulations
When Mary Cates was told she had cancer, she didn’t flinch . . . either time.
Cracking the cancer code
Cancer is a genomic disease, and Harshad Mahadeshwar’s job is to decode its weaknesses.
Training days
MD安德森系统由毕业后医学教育自主研发的专家提振
With two, they’ve won
在一年内，此二人院长是费尽了成就
发动免疫系统的攻击犬
第一个药物来改善的人，因为它没有做末期黑色素瘤的作品生存：直接攻击肿瘤。
Trial fits attack on melanoma to a T
By boosting the number of T cells in his patients, Patrick Hwu is watching their immune systems defeat cancer.
The clone wars
Michael Gunter’s had time to think about melanoma.
Born to beat cancer
玛丽特·彼得森可以遗传易患黑色素瘤，但疾病是没有对手对于她和她的团队。
Strength in numbers: Send in the reinforcements
当不能杀死病人的癌症免疫系统的T细胞在实验室中获得的那些相同的肿瘤细胞中了一枪，这是另外一回事。
Building a better T cell
Treatments relying on T cells, a key component of the body’s immune system, have had significant success, but a new experimental method customizes naturally produced cells to sharpen their attack on cancer.
When good genetic mutation goes bad
Generally speaking, hypermutation and DNA damage in a cell are bad things. That is, unless you’re talking about an immune system B cell.
夜间计划：护理，不间断
夜间计划确保从白天到晚上病人的无缝过渡
夜是一个很好的适合日
When Lakeisha Day sees a patient in the wee hours, she knows she needs to make the most of their limited time together.
Getting a lot out of giving
Gloria Ayala walked into a hospital room and found a mother pacing while her daughter lay in bed. When Ayala was greeted with a big hug, she realized the experience was what being an MD Anderson volunteer was all about.
无处藏身
通过公开癌细胞，荧光，使外科医生的工作更容易。
Team is the heart of the Head and Neck Center
Treating cancer while preserving form and function.
Free of cancer and full of thanks
Gift of gratitude boosts head and neck cancer research
专业领域
Growing network of hospitals expands opportunities to end a global crisis